IMMU-18. HUMANIZED ANTI-CD47 ANTIBODY COMBINED WITH AN AGONIST ANTI-CD40 ANTIBODY IS AN EFFECTIVE TREATMENT FOR DIPG XENOGRAFTS WITH CRANIOSPINAL DISSEMINATION

INTRODUCTION: DIPG is the most common malignant brainstem tumor in children. The resistance of DIPG to standard treatments along with inoperability of this tumor because of the anatomical location leave DIPG patients with dismal prognosis. Multiple studies revealed that DIPG patients have only a few...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Gholamin, Sharareh, Kahn, Suzana, Esparza, Rogelio, Weissman, Irving, Mitra, Siddhartha, Cheshier, Samuel
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475118/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars